| Citation: |
LIU Yanqi, ZHENG Guanqun, CHEN Zhixian, JIN Xiaoqi, SHENG Xiaodong, WANG Zhiqiang. Correlation between plasma trimethylamine-N-oxide and coronary heart disease and its effect on the prognosis of patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 90-96. DOI: 10.7619/jcmp.20221667
|
To investigate the correlation between trimethylamine-N-oxide (TMAO) and coronary heart disease (CHD) and its impact on the prognosis of patients with CHD.
From May 2019 to December 2020, 200 CHD patients who underwent coronary angiography (CHD group) and 124 healthy subjects with negative coronary angiography or coronary CT results (control group) were selected. The level of TMAO was determined by high performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS). According to the median plasma TMAO value of 3.14 μmol/L, the CHD group was divided into group A(low TMAO CHD group) and group B (high TMAO CHD group). Gensini score was used to evaluate the degree of coronary artery disease. The levels of TMAO in the control group and CHD group were analyzed, and the correlation between the degree of coronary artery disease and TMAO level was analyzed. The influencing factors of CHD and TMAO were analyzed by logistic regression. Patients with CHD were followed up for 1 year, death, myocardial infarction, revascularization and other adverse events were recorded. Kaplan-Meier survival and risk curves were drawn to further compare the incidence of adverse events between the group A and group B.
The level of TMAO in the CHD group was significantly higher than that in the control group (P=0.001). High TMAO level was a risk factor for CHD (OR=7.54, 95%CI, 4.27 to 13.33, P < 0.001); in patients with CHD, high body mass index (BMI) was a risk factor for elevated TMAO (OR=1.48, 95%CI, 1.09 to 2.00, P=0.001). The Gensini score of the group A was significantly lower than that of the group B (P < 0.05). Serum TMAO level in CHD patients was positively correlated with Gensini score (r=-0.449, P < 0.001). There was a significant difference in survival curve between the group A and group B (P=0.005). In group B, the survival rate decreased and the hazard rate increased.
TMAO is one of the influencing factors for CHD, and the severity of lesions and cardiovascular adverse events in CHD patients are related to TMAO level. TMAO can be used as a diagnostic and prognostic marker for CHD.
| [1] |
ZHOU M G, WANG H D, ZENG X Y, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158. doi: 10.1016/S0140-6736(19)30427-1
|
| [2] |
CASE B C, WAKSMAN R. Coronary heart disease: have we reached a plateau in primary prevention[J]. J Am Heart Assoc, 2020, 9(7): e04963. doi: 10.1161/JAHA.120.016034
|
| [3] |
SABOURET P, SAVAGE M P, FISCHMAN D, et al. Complexity of antiplatelet therapy in coronary artery disease patients[J]. Am J Cardiovasc Drugs, 2021, 21(1): 21-34. doi: 10.1007/s40256-020-00414-0
|
| [4] |
LAM V, SU J D, HSU A, et al. Intestinal microbial metabolites are linked to severity of myocardial infarction in rats[J]. PLoS One, 2016, 11(8): e0160840. doi: 10.1371/journal.pone.0160840
|
| [5] |
WANG Z N, TANG W H, BUFFA J A, et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide[J]. Eur Heart J, 2014, 35(14): 904-910. doi: 10.1093/eurheartj/ehu002
|
| [6] |
HEIANZA Y, MA W J, DIDONATO J A, et al. Long-term changes in gut microbial metabolite trimethylamine N-oxide and coronary heart disease risk[J]. J Am Coll Cardiol, 2020, 75(7): 763-772. doi: 10.1016/j.jacc.2019.11.060
|
| [7] |
WARRIER M, SHIH D M, BURROWS A C, et al. The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance[J]. Cell Rep, 2015, 10(3): 326-338. doi: 10.1016/j.celrep.2014.12.036
|
| [8] |
中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志, 2018, 46(9): 680-694. doi: 10.3760/cma.j.issn.0253-3758.2018.09.004
|
| [9] |
中华医学会心血管病学分会介入心脏病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 中华心血管病杂志编辑委员会. 中国经皮冠状动脉介入治疗指南(2016)[J]. 中华心血管病杂志, 2016, 44(5): 382-400. doi: 10.3760/cma.j.issn.0253-3758.2016.05.006
|
| [10] |
VALDES A M, WALTER J, SEGAL E, et al. Role of the gut microbiota in nutrition and health[J]. BMJ, 2018, 361: k2179.
|
| [11] |
SKYE S M, ZHU W F, ROMANO K A, et al. Microbial transplantation with human gut commensals containing CutC is sufficient to transmit enhanced platelet reactivity and thrombosis potential[J]. Circ Res, 2018, 123(10): 1164-1176. doi: 10.1161/CIRCRESAHA.118.313142
|
| [12] |
PETRIELLO M C, HOFFMAN J B, SUNKARA M, et al. Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors[J]. J Nutr Biochem, 2016, 33: 145-153. doi: 10.1016/j.jnutbio.2016.03.016
|
| [13] |
WANG Z N, ROBERTS A B, BUFFA J A, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis[J]. Cell, 2015, 163(7): 1585-1595. doi: 10.1016/j.cell.2015.11.055
|
| [14] |
ARGYRIDOU S, DAVIES M J, BIDDLE G J H, et al. Evaluation of an 8-week vegan diet on plasma trimethylamine-N-oxide and postchallenge glucose in adults with dysglycemia or obesity[J]. J Nutr, 2021, 151(7): 1844-1853. doi: 10.1093/jn/nxab046
|
| [15] |
DEHGHAN P, FARHANGI M A, NIKNIAZ L, et al. Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: an exploratory systematic review and dose-response meta-analysis[J]. Obes Rev, 2020, 21(5): e12993.
|
| [16] |
SCHUGAR R C, SHIH D M, WARRIER M, et al. The TMAO-producing enzyme flavin-containing monooxygenase 3 regulates obesity and the beiging of white adipose tissue[J]. Cell Rep, 2017, 19(12): 2451-2461. doi: 10.1016/j.celrep.2017.05.077
|
| [17] |
金雷, 王晓宇, 陈忠锐. 冠心病患者血清non-HDL-C、动脉粥样硬化指数与冠状动脉狭窄程度的关系研究[J]. 中国循证心血管医学杂志, 2019, 11(2): 175-177, 183. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX201902012.htm
|
| [18] |
SUN X L, JIAO X F, MA Y R, et al. Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome[J]. Biochem Biophys Res Commun, 2016, 481(1/2): 63-70.
|
| [19] |
张亚男, 王思明, 于雪, 等. 三甲胺氧化物与冠心病合并2型糖尿病患者冠状动脉病变情况的相关性分析[J]. 中华心血管病杂志, 2021, 49(7): 680-686. doi: 10.3760/cma.j.cn112148-20200902-00696
|
| [20] |
TAN Y, SHENG Z X, ZHOU P, et al. Plasma trimethylamine N-oxide as a novel biomarker for plaque rupture in patients with ST-segment-elevation myocardial infarction[J]. Circ Cardiovasc Interv, 2019, 12(1): e007281. doi: 10.1161/CIRCINTERVENTIONS.118.007281
|
| [21] |
GUASTI L, GALLIAZZO S, MOLARO M, et al. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis[J]. Intern Emerg Med, 2021, 16(1): 201-207. doi: 10.1007/s11739-020-02470-5
|
| [22] |
YAO M E, LIAO P D, ZHAO X J, et al. Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis[J]. BMC Cardiovasc Disord, 2020, 20(1): 7. doi: 10.1186/s12872-019-01310-5
|
| [23] |
张亚男, 于雪. 血浆氧化三甲胺水平对冠心病患者预后的预测作用: 剂量-反应Meta分析[J]. 中国循环杂志, 2021, 36(2): 149-155. doi: 10.3969/j.issn.1000-3614.2021.02.007
|
| [24] |
LI X S, OBEID S, KLINGENBERG R, et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors[J]. Eur Heart J, 2017, 38(11): 814-824.
|
| [25] |
MENG G N, ZHOU X Y, WANG M L, et al. Gut microbe-derived metabolite trimethylamine N-oxide activates the cardiac autonomic nervous system and facilitates ischemia-induced ventricular arrhythmia via two different pathways[J]. EBioMedicine, 2019, 44: 656-664. doi: 10.1016/j.ebiom.2019.03.066
|
| [26] |
SUZUKI T, HEANEY L M, BHANDARI S S, et al. Trimethylamine N-oxide and prognosis in acute heart failure[J]. Heart, 2016, 102(11): 841-848. doi: 10.1136/heartjnl-2015-308826
|
| [27] |
TRØSEID M, UELAND T, HOV J R, et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure[J]. J Intern Med, 2015, 277(6): 717-726. doi: 10.1111/joim.12328
|
| [28] |
ORGAN C L, OTSUKA H, BHUSHAN S, et al. Choline diet and its gut microbe-derived metabolite, trimethylamine N-oxide, exacerbate pressure overload-induced heart failure[J]. Circ Heart Fail, 2016, 9(1): e002314.
|
| [29] |
YANG J J, SHU X O, HERRINGTON D M, et al. Circulating trimethylamine N-oxide in association with diet and cardiometabolic biomarkers: an international pooled analysis[J]. Am J Clin Nutr, 2021, 113(5): 1145-1156. doi: 10.1093/ajcn/nqaa430
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: